[Coronary blood flow and oxygen consumption of human heart under the effect of hexobendine].
D001158:Arteries; D001794:Blood Pressure / Q000187:drug effects*; D003331:Coronary Vessels / Q000187:drug effects*; D003864:Depression, Chemical; D005029:Ethylenediamines / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006261:Headache / Q000139:chemically induced; D006321:Heart / Q000187:drug effects*; D006331:Heart Diseases / Q000188:drug therapy / Q000378:metabolism*; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D007275:Injections, Intravenous; D009206:Myocardium / Q000378:metabolism; D009325:Nausea / Q000139:chemically induced; D010101:Oxygen Consumption / Q000187:drug effects*; D012039:Regional Blood Flow / Q000187:drug effects*; D013268:Stimulation, Chemical; D014665:Vasodilator Agents / Q000494:pharmacology; D014717:Vertigo / Q000139:chemically induced
D005029:Ethylenediamines; D014665:Vasodilator Agents
Coronardurchblutung und Sauerstoffversorgung des menschlichen Herzens unter dem Einfluss von Hexobendin.